Cleerly LABS vs PMcardio
AI Verdict
Choose Cleerly LABS if…
Choose Cleerly LABS if your primary goal is a detailed, quantitative assessment of coronary artery disease through CCTA. This tool is ideal for comprehensive plaque characterization, stenosis quantification, and tracking disease progression over time, particularly for personalized heart disease management and risk assessment. It's best suited for situations requiring in-depth anatomical and pathological insights beyond basic cardiac function.
View Cleerly LABS →Choose PMcardio if…
Choose PMcardio if you need rapid, AI-powered interpretation of ECGs for immediate clinical decision-making at the point of care. This tool excels in quickly identifying over 50 cardiac conditions, including critical events like STEMI/OMI and reduced LVEF, making it highly valuable in emergency medicine, internal medicine, or any setting where swift and accurate ECG analysis is paramount for guiding timely interventions.
View PMcardio →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Cleerly LABS | PMcardio |
|---|---|---|
| Pricing | Per analysis | Freemium |
| Deployment | Cloud-based (AWS), web-based application, with on-site Cleerly Proxy for data transfer. | Mobile app (iOS and Android), Web platform, Enterprise integrations with EHR/CVIS and EMS systems |
| FDA Status | 1 AI-estimated | Pending AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
PMcardioPMcardio offers a mobile app and web platform, allowing for instant AI-powered ECG interpretations at the point of care, which suggests high accessibility and ease of use for various healthcare professionals. Cleerly LABS is a web-based application with an on-site proxy for data transfer, which might involve a more complex setup and workflow.
Clinical Value
PMcardioPMcardio is clinically validated in over 25 studies and detects over 50 cardiac conditions from ECGs, including early STEMI detection with higher sensitivity and reduced false alarms compared to standard methods. Cleerly LABS, while FDA-cleared for comprehensive CCTA analysis and ischemia detection, has fewer publicly cited validation studies (CREDENCE and PACIFIC trials) and focuses on a different diagnostic modality.
Pricing & Value
PMcardioPMcardio offers a freemium model with a free plan for up to 5 ECG analyses per month, making it accessible for individual clinicians to try and use. Cleerly LABS has a retail price of $1500 per analysis, currently discounted to $750, with the CCTA scan cost being separate and often out-of-pocket, indicating a higher cost barrier for initial adoption.
Enterprise Readiness
PMcardioPMcardio offers enterprise integrations with EHR/CVIS and EMS systems, built for system-wide rollout with features like central report management, configurable user permissions, and robust security. Cleerly LABS also offers integration with PACS, RIS, and EHR via a Cleerly Proxy, and is cloud-based, but PMcardio's explicit mention of system-wide deployment, single integration, and comprehensive care coordination features suggest a more mature enterprise offering.
Innovation
PMcardioPMcardio features 'Queen of Hearts' for STEMI/OMI detection with AI explainability (ECGxplainu2122) using heatmaps, and 'LVsense' for reduced LVEF detection, showcasing advanced AI capabilities and transparency. Cleerly LABS provides comprehensive plaque assessment and stenosis quantification with 3D visualization, and ischemia detection, which are innovative for CCTA analysis, but PMcardio's explainable AI and broader range of real-time ECG interpretations give it an edge in innovation.
Support & Docs
PMcardioPMcardio provides a Help Center with user-friendly tutorials and manuals, FAQs, and detailed regulatory and security documentation. While Cleerly offers resources for providers and patients, the explicit mention of a comprehensive Help Center and various legal documents for PMcardio suggests a more robust and easily accessible support and documentation framework.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Cleerly LABS | PMcardio |
|---|---|---|
| Tool Name | Cleerly LABS | PMcardio |
| Description | AI-powered, FDA-cleared web-based software for comprehensive analysis of coronary CT angiography (CCTA) to detect, quantify, and characterize atherosclerosis and stenosis, aiding in personalized heart disease management. | CE-certified AI platform that interprets ECGs to assess over 50 cardiac conditions rapidly and accurately. Clinically validated in more than 25 studies and trusted by over 100,000 clinicians, it delivers rapid, expert-level interpretations, empowering various healthcare professionals to act with confidence at the point of care. |
| Company | Cleerly | Powerful Medical |
| Primary Data Input | Coronary CT angiography (CCTA) | ECGs |
| Key Features (Examples) | AI-powered CCTA image analysis, Comprehensive coronary plaque assessment (volume, type), Stenosis detection and quantification, Ischemia detection (with Cleerly ISCHEMIA module), 3D visualization of coronary arteries | Instant AI-powered ECG interpretations, Detection of 50+ ECG findings (including STEMI/OMI, rhythms, reduced LVEF, conduction disorders), Queen of Heartsu2122 - STEMI and OMI Detection, LVsenseu2122 - Reduced LVEF Detection, ECGxplainu2122 - Visual AI Explainability with heatmaps |
Videos
Demos, reviews, and walkthroughs featuring Cleerly LABS and PMcardio.
Frequently Asked Questions
More Comparisons
More matchups featuring Cleerly LABS or PMcardio
Backers
Who funded each tool's parent company.